復星醫藥計畫在全球拓展腫瘤以外的業務，其多元化的阿茲海默症策略是推動這一目標實現的關鍵。
在最近接受 Fierce 採訪時，復星醫藥聯席總裁王新利醫學博士詳細介紹了公司如何利用最近的兩項交易，迅速建立其在阿茲海默症領域的產品組合，這是公司在美國建立獨立能力的多步驟路線圖的一部分。
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
常見問題
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
